Astrana Health, Inc.
ASTHUS売上高
$3.2B
百万USD
営業利益
$79M
百万USD
純利益
$22M
百万USD
ROE
2.9%
最新FY
EPS
$0.46
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $176M | $13M | $0.30 |
| FY2021 | Q2 | $176M | $13M | $0.28 |
| FY2021 | Q3 | $227M | $34M | $0.74 |
| FY2021 | FY | $774M | $74M | $1.63 |
| FY2022 | Q1 | $263M | $14M | $0.31 |
| FY2022 | Q2 | $270M | $11M | $0.25 |
| FY2022 | Q3 | $317M | $26M | $0.56 |
| FY2022 | FY | $1.1B | $45M | $0.99 |
| FY2023 | Q1 | $337M | $13M | $0.28 |
| FY2023 | Q2 | $348M | $13M | $0.28 |
| FY2023 | Q3 | $348M | $22M | $0.47 |
| FY2023 | FY | $1.4B | $61M | $1.29 |
| FY2024 | Q1 | $404M | $15M | $0.31 |
| FY2024 | Q2 | $486M | $19M | $0.40 |
| FY2024 | Q3 | $479M | $16M | $0.33 |
| FY2024 | FY | $2.0B | $43M | $0.90 |
| FY2025 | Q1 | $965M | $14M | $0.29 |
| FY2025 | Q2 | $655M | $9M | $0.19 |
| FY2025 | Q3 | $956M | $0M | $0.01 |
| FY2025 | FY | $3.2B | $22M | $0.46 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $561M | $687M | $774M | $1.1B | $1.4B | $2.0B | $3.2B |
| 営業利益 | $-7M | $35M | $88M | $32M | $81M | $98M | $104M | $85M | $89M | $79M |
| 純利益 | $-9M | $26M | $11M | $14M | $38M | $74M | $45M | $61M | $43M | $22M |
| 総資産 | $20M | $491M | $513M | $729M | $817M | $852M | $966M | $933M | $1.4B | $2.2B |
| 純資産 | $1M | $164M | $182M | $192M | $331M | $460M | $544M | $617M | $717M | $793M |
| 自己資本 | $-1M | $160M | $181M | $192M | $331M | $455M | $543M | $614M | $713M | $779M |
| 営業CF | - | $52M | $25M | $14M | $46M | $70M | $82M | $68M | $52M | $115M |
| EPS | - | $0.90 | $0.29 | $0.39 | $1.01 | $1.63 | $0.99 | $1.29 | $0.90 | $0.46 |
| BPS | $-0.22 | $23.01 | $5.04 | $3.63 | $6.06 | $8.12 | $9.45 | $11.08 | $12.67 | $14.02 |
| ROE | 736.1% | 16.1% | 6.0% | 7.4% | 11.4% | 16.2% | 8.3% | 9.9% | 6.1% | 2.9% |